Misoprostol is a synthetic form of prostaglandin, a naturally occurring fatty acid that plays a role in protecting the stomach lining and stimulating smooth muscle contractions. It has two broad categories of use: preventing stomach ulcers caused by pain medications and managing several aspects of reproductive health, including medication abortion, labor induction, and postpartum bleeding.
Preventing Stomach Ulcers From Pain Medications
Misoprostol’s original and FDA-approved use is preventing gastric ulcers in people who take nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, naproxen, or aspirin on a long-term basis. NSAIDs work by blocking the production of prostaglandins, which is how they reduce pain and inflammation. The problem is that prostaglandins also protect the stomach lining by promoting mucus and bicarbonate secretion, which neutralize stomach acid. When NSAID use suppresses those protective prostaglandins, the stomach becomes vulnerable to ulcers.
Misoprostol fills that gap. It reduces the amount of acid the stomach produces while also boosting mucus and bicarbonate output, essentially restoring the protective barrier that NSAIDs strip away. The standard dose for ulcer prevention is 200 micrograms taken four times daily with food, with the last dose at bedtime. A lower dose of 100 micrograms can be used if side effects are a problem. It’s taken for as long as NSAID therapy continues.
This use carries a significant safety restriction for women of childbearing age. Because misoprostol causes uterine contractions, it can trigger miscarriage, premature labor, or birth defects. Women prescribed it for ulcer prevention must have a confirmed negative pregnancy test within the prior two weeks and use reliable contraception throughout treatment.
Medication Abortion
Misoprostol is one half of the two-drug regimen used for medication abortion through ten weeks of pregnancy. The process starts with mifepristone, a 200 mg pill taken by mouth that blocks progesterone, the hormone needed to sustain a pregnancy. Then, 24 to 48 hours later, 800 micrograms of misoprostol is taken buccally (placed between the cheek and gum and allowed to dissolve). The misoprostol triggers uterine contractions that expel the pregnancy tissue.
When combined with mifepristone, buccal or vaginal misoprostol at 800 micrograms is more effective than the same dose taken orally. The FDA approved this regimen over 20 years ago after extensive review of its safety and efficacy.
Misoprostol is also used to manage incomplete spontaneous miscarriage, helping the body pass remaining tissue without the need for a surgical procedure. For this purpose, single doses of 600 to 800 micrograms given vaginally, orally, or under the tongue are equally effective at achieving complete uterine evacuation.
Labor Induction and Cervical Ripening
When labor needs to be induced, the cervix often has to soften and dilate first, a process called cervical ripening. Misoprostol is widely used for this purpose. It can be given orally, vaginally, buccally, or under the tongue, though not all routes perform equally.
Vaginal misoprostol tends to work faster than buccal administration. One randomized trial of 300 women found that vaginal dosing shortened the time to vaginal delivery by about 8 hours compared with buccal dosing, with a higher rate of delivery within 24 hours and fewer cesarean sections performed for fetal heart rate concerns. Sublingual (under the tongue) administration produces rapid absorption and higher peak blood levels, but it also increases the risk of overly frequent uterine contractions, so it’s not recommended for routine cervical ripening.
The American College of Obstetricians and Gynecologists recommends a trauma-informed approach when discussing ripening options, recognizing that the choice of oral versus vaginal methods may matter to individual patients for personal reasons.
Treating and Preventing Postpartum Hemorrhage
Severe bleeding after childbirth remains one of the leading causes of maternal death worldwide. Misoprostol serves as an alternative when the first-line medications for controlling postpartum hemorrhage aren’t available, which makes it especially important in low-resource settings where refrigerated drugs may not be accessible. Unlike other uterine-contracting medications, misoprostol is stable at room temperature and can be given by multiple routes: orally, under the tongue, vaginally, or rectally.
For treatment of active hemorrhage, the International Federation of Gynecology and Obstetrics recommends 1,000 micrograms given rectally. For prevention, lower doses are used. The number needed to treat is 18, meaning that for every 18 women given misoprostol preventively, one case of postpartum hemorrhage is avoided. It does carry more side effects than conventional options, particularly fever and shivering, so it’s generally reserved for situations where those first-line drugs aren’t an option.
How It Works in the Body
Misoprostol mimics prostaglandin E2, a signaling molecule that acts on four types of receptors found throughout the body. In the stomach, it activates pathways that reduce acid secretion and increase the protective mucus coating. In the uterus, it activates receptors that increase calcium levels inside smooth muscle cells, causing them to contract. This dual action explains why a single drug can both protect the stomach and induce labor or abortion.
The balance between contraction and relaxation depends on which receptors are most active in a given tissue. Two of the four receptor types promote muscle contraction by raising intracellular calcium, while the other two promote relaxation. In uterine tissue, the contraction-promoting receptors dominate misoprostol’s response, which is why it so reliably stimulates the uterus.
Common Side Effects
Diarrhea is the most frequent side effect, especially with oral dosing. Stomach pain, bloating, gas, and heartburn are also common. These gastrointestinal effects often improve as the body adjusts to the medication.
The route of administration significantly affects which side effects you experience and how severe they are. Vaginal administration causes substantially less diarrhea than oral, buccal, or sublingual routes. In one trial comparing vaginal and oral dosing at 800 micrograms, patients receiving the vaginal dose had roughly 80% less diarrhea. Sublingual dosing produces the most gastrointestinal complaints overall: one study found it caused 2.5 times more diarrhea, 1.7 times more nausea, and nearly 3 times more vomiting compared with vaginal administration.
Rare but serious side effects include heavy uterine bleeding and severe abdominal cramping. Less commonly reported effects include fever, chills, dizziness, headache, and skin rash. Fever and shivering are particularly associated with higher doses used in obstetric settings.